LAPTM5 and Miyoshi myopathy: To further establish that autophagy mediates the pro‐resistance effects of LAPTM5 in MM, we employed a knockdown strategy targeting ATG5 (sh‐ATG5) in OPM2/VR cells (Figure 6A,B), as ATG5 is a pivotal regulator in autophagy initiation [41].